Favorable treatment response to high-grade sarcoma in neurofibromatosis 1.

Talukder, Michelle H; Patel, Mauli M; Al-Saghir, Tala; Katato, Ghadir K; Poulik, Janet; Powell, William J; Kemp, Alysia K; Miller, Steven; Bell, Danielle; Taub, Jeffrey W

Talukder, Michelle H; Patel, Mauli M; Al-Saghir, Tala; Katato, Ghadir K; Poulik, Janet; Powell, William J; Kemp, Alysia K; Miller, Steven; Bell, Danielle; Taub, Jeffrey W.

Afiliação

Talukder MH; Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan, USA.
Patel MM; Wayne State University School of Medicine, Detroit, Michigan, USA.
Al-Saghir T; Wayne State University School of Medicine, Detroit, Michigan, USA.
Katato GK; Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA.
Poulik J; Department of Pathology, Children's Hospital of Michigan, Detroit, Michigan, USA.
Powell WJ; Department of Radiology, Children's Hospital of Michigan, Detroit, Michigan, USA.
Kemp AK; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA.
Miller S; Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan, USA.
Bell D; Karmanos Cancer Center, Detroit, Michigan, USA.
Taub JW; Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan, USA.

Pediatr Blood Cancer ; 70(10): e30500, 2023 10.

Article em En | MEDLINE | ID: mdl-37336842

Assuntos

Neurofibromatose 1; Sarcoma; Humanos; Neurofibromatose 1/complicações; Neurofibromatose 1/genética; Sarcoma/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neurofibromatose 1 Limite: Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google